Post IPO investors in New York City
Updated 16 Nov 2026
Venture funds
2 funds, by portfolio companies funded in the last 12 months| # | Fund | Sectors | Stages | Leads | Funded, 12 months |
|---|---|---|---|---|---|
| 1 | Casdin Capital Casdin Capital does fundamental research investing in life sciences and healthcare, with recent companies Multiply Labs and Thyme Care. New York, United States |
Health care, Biotech | Seed, Early stage venture, Late stage venture | 15% | 5 |
| 2 | Colle Capital Partners Colle Capital is a data focused and opportunistic global technology venture fund, and recently backed Findigs and RADAR. New York, United States |
Commerce, Artificial intelligence | Seed, Early stage venture, Late stage venture | 12% | 3 |
Table 1. Post IPO investors in New York City: venture capital and micro VC funds ranked by companies whose most recent round closed in the last 12 months. Leads is the share of all recorded investments where the fund was lead investor. Source: FundingWatcher. Data as of 16 November 2026.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Investor | Type | Location | Phone | |
|---|---|---|---|---|
| Tiger Global Management | Hedge fund | New York, United States | •••@tigerglobal.com | 212-98••• |
| BlackRock | Investment bank | New York, United States | •••@blackrock.com | 212-81••• |
| Morgan Stanley | Investment bank | New York, United States | •••@morganstanley.com | +1 212••• |
| Invus | Private equity firm | New York, United States | •••@invus.com | +1 (21••• |
| Casdin Capital | Venture capital firm | New York, United States | •••@casdincapital.com | +1 212••• |
| Hearst Ventures | Corporate venture arm | New York, United States | •••@hearst.com | (888) ••• |
| New Leaf Venture Partners | Venture capital firm | New York, United States | •••@nlvpartners.com | 646-87••• |
| Apollo | Private equity firm | New York, United States | •••@apollo.com | 212-51••• |
8 rows of the CSV in 5 of its 15 columns, email and phone masked.
| Firm | Person | Title | Verified email | |
|---|---|---|---|---|
| OrbiMed | W••• P••• | Managing Director | p•••@orbimed.com | In the CSV |
| Invus | K••• B••• | Managing Director | k•••@invus.com | In the CSV |
| Casdin Capital | B••• C••• | Senior Managing Director | b•••@casdincapital.com | In the CSV |
| New Leaf Venture Partners | V••• L••• | Managing Director | v•••@nlvpartners.com | In the CSV |
| Aisling Capital | E••• A••• | Partner | e•••@aislingcapital.com | In the CSV |
5 verified partner contact rows from organizations on this list, names and emails masked.
- 105 of the 188 post ipo investors in New York City have a published email address, 131 a phone number and 175 a website.
- Tiger Global Management has the most recorded investments, 1,260, 724 of them as lead investor.
- 24 of them are investors in at least one company that closed its most recent round in the last 12 months.
- Tiger Global Management is an investor in 27 of those companies, more than any other investor on this list.
- The newest round among their portfolio companies is Easol's $20.0M Series A on 28 October 2026.
- Software is the most common sector across their 864 portfolio companies (71%).
- Early stage venture is the most common investment stage, recorded for 137 of them (73%).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Post IPO investors in New York City
30 of 188, most investments first| # | Investor | Type | Location | Invests in | Latest portfolio companies | Funded, 12 months | Investments | Lead | Exits | Phone | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Tiger Global Management | Hedge fund, Private equity firm | New York, United States | Fintech, Artificial intelligence | Harbinger, Easol, Mach9 | 27 | 1,260 | 724 | 223 | •••@tigerglobal.com | 212-98••• | In the CSV |
| 2 | OrbiMed | Private equity firm | New York, United States | Health care, Biotech | Triveni Bio, Windward Bio, Terremoto Biosciences | 8 | 810 | 276 | 304 | +1 (21••• | In the CSV | |
| 3 | BlackRock | Investment bank, Private equity firm | New York, United States | Artificial intelligence, Fintech | Snorkel AI, Deepgram, Groq | 16 | 472 | 180 | 180 | •••@blackrock.com | 212-81••• | In the CSV |
| 4 | Morgan Stanley | Investment bank | New York, United States | Fintech, Health care | Recykal, Daloopa, Vestwell | 3 | 381 | 121 | 173 | •••@morganstanley.com | +1 212••• | In the CSV |
| 5 | Perceptive Advisors | Hedge fund | New York, United States | Health care, Biotech | Bridge to Life, CereVasc, Talkiatry | 3 | 352 | 116 | 196 | (646) ••• | In the CSV | |
| 6 | JP Morgan | Investment bank, Private equity firm | New York, United States | Fintech, Artificial intelligence | Capitolis, Tabby, Socure | 9 | 322 | 141 | 107 | +1 212••• | In the CSV | |
| 7 | Citi | Investment bank | New York, United States | Fintech, Artificial intelligence | Ramp, Capitolis, Qupital | 10 | 312 | 111 | 84 | (212) ••• | In the CSV | |
| 8 | Invus | Private equity firm | New York, United States | Health care, Biotech | Lycia Therapeutics, Triveni Bio | 2 | 300 | 52 | 99 | •••@invus.com | +1 (21••• | In the CSV |
| 9 | Blackstone | Private equity firm | New York, United States | Fintech, Cybersecurity | Pentera, Idrx, Symphony | 292 | 158 | 109 | +1 (21••• | In the CSV | ||
| 10 | Casdin Capital | Venture capital firm | New York, United States | Health care, Biotech | Multiply Labs, Thyme Care, Cerevance | 5 | 248 | 36 | 93 | •••@casdincapital.com | +1 212••• | In the CSV |
| 11 | Hearst Ventures | Corporate venture arm | New York, United States | Artificial intelligence, Commerce | Loora | 1 | 199 | 33 | 57 | •••@hearst.com | (888) ••• | In the CSV |
| 12 | New Leaf Venture Partners | Venture capital firm | New York, United States | Health care, Artificial intelligence | Arvist, Truveris, Qlaris Bio | 197 | 52 | 60 | •••@nlvpartners.com | 646-87••• | In the CSV | |
| 13 | Pfizer Venture Investments | Corporate venture arm | New York, United States | Biotech, Health care | FoRx Therapeutics | 1 | 195 | 51 | 52 | In the CSV | ||
| 14 | Apollo | Private equity firm | New York, United States | Fintech, Health care | CAIS, Kashable | 2 | 182 | 109 | 78 | •••@apollo.com | 212-51••• | In the CSV |
| 15 | Aisling Capital | Private equity firm | New York, United States | 182 | 31 | 105 | •••@aislingcapital.com | (212) ••• | In the CSV | |||
| 16 | Goldman Sachs Growth Equity | Private equity firm | New York, United States | Fintech, Cybersecurity | New York Shipping Exchange, Limble CMMS, Crux | 155 | 90 | 61 | •••@goldmansachs.org | 415568••• | In the CSV | |
| 17 | RTW Investments | Hedge fund | New York, United States | Biotech, Health care | Windward Bio, CORXEL Pharmaceuticals | 2 | 142 | 41 | 80 | •••@rtwfunds.com | +1 646••• | In the CSV |
| 18 | Catalio Capital Management | Venture capital firm | New York, United States | Biotech, Health care | Volastra Therapeutics, PinkDx, Clasp Therapeutics | 134 | 32 | 30 | •••@cataliocapital.com | (410) ••• | In the CSV | |
| 19 | Third Point Ventures | Hedge fund, Venture capital firm | New York, United States | Cybersecurity, Artificial intelligence | Channel Medsystems | 1 | 124 | 51 | 39 | •••@thirdpoint.com | +1 212••• | In the CSV |
| 20 | The Global Emerging Markets Group | Private equity firm | New York, United States | Artificial intelligence, Hardware | KaJ Labs, Spendwisor Inc | 123 | 75 | 42 | •••@gemny.com | (212) ••• | In the CSV | |
| 21 | Access Industries | Hedge fund, Private equity firm | New York, United States | Commerce, Artificial intelligence | Tripledot Studios, Gett, TAP Network | 101 | 28 | 35 | +1 212••• | In the CSV | ||
| 22 | Fortress Investment Group | Private equity firm | New York, United States | Hardware, Fintech | Razor Group, Pivotal Commware, AURA Network Systems | 99 | 61 | 44 | •••@fortress.com | +1 212••• | In the CSV | |
| 23 | Bienville Capital | Hedge fund, Startup incubator | New York, United States | Fintech, Health care | Renterra, August Schools | 2 | 99 | 15 | 15 | •••@bienvillecapital.com | 212-22••• | In the CSV |
| 24 | Colle Capital Partners | Venture capital firm | New York, United States | Commerce, Artificial intelligence | Findigs, RADAR, Qureos | 3 | 97 | 12 | 12 | •••@collecapital.com | +352 3••• | In the CSV |
| 25 | Blue Owl | Private equity firm | New York, United States | Health care, Biotech | Lycia Therapeutics, Windward Bio, Vestwell | 4 | 84 | 38 | 33 | •••@blueowl.com | In the CSV | |
| 26 | Cowen Healthcare Investments | Venture capital firm | New York, United States | Biotech | MBrace Therapeutics | 80 | 19 | 43 | •••@gmail.com | +1-646••• | ||
| 27 | D. E. Shaw & Co. | Private equity firm | New York, United States | Cybersecurity, Artificial intelligence | ThreatLocker, Backslash Security, Neural Concept | 3 | 74 | 28 | 21 | •••@deshaw.com | +1 212••• | In the CSV |
| 28 | Feenix Venture Partners | Venture debt fund | New York, United States | Fintech, Health care | League Network | 73 | 44 | 8 | •••@feenixpartners.com | (646) ••• | In the CSV | |
| 29 | Veronis Suhler Stevenson | Private equity firm | New York, United States | 70 | 61 | 29 | +1 212••• | In the CSV | ||||
| 30 | Soros Fund Management | Private equity firm, Venture capital firm | New York, United States | Fintech, Hardware | dv01, Airslide Systems, Yellowbrix | 69 | 17 | 26 | In the CSV |
Table 2. Post IPO investors in New York City: the first 30 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 188.
Most active in the last 12 months
By portfolio companies funded| # | Investor | Location | Funded, 12 months | Portfolio | Latest |
|---|---|---|---|---|---|
| 1 | Tiger Global Management | New York, United States | 27 | 289 | Harbinger, Easol, Mach9 |
| 2 | BlackRock | New York, United States | 16 | 56 | Snorkel AI, Deepgram, Groq |
| 3 | Citi | New York, United States | 10 | 48 | Ramp, Capitolis, Qupital |
| 4 | JP Morgan | New York, United States | 9 | 23 | Capitolis, Tabby, Socure |
| 5 | OrbiMed | New York, United States | 8 | 46 | Triveni Bio, Windward Bio, Terremoto Biosciences |
| 6 | Casdin Capital | New York, United States | 5 | 13 | Multiply Labs, Thyme Care, Cerevance |
| 7 | Moore Strategic Ventures | New York, United States | 4 | 14 | HiddenLayer, Utilidata, Sierra Space |
| 8 | Blue Owl | New York, United States | 4 | 9 | Lycia Therapeutics, Windward Bio, Vestwell |
| 9 | Perceptive Advisors | New York, United States | 3 | 11 | Bridge to Life, CereVasc, Talkiatry |
| 10 | D. E. Shaw & Co. | New York, United States | 3 | 9 | ThreatLocker, Backslash Security, Neural Concept |
| 11 | Morgan Stanley | New York, United States | 3 | 31 | Recykal, Daloopa, Vestwell |
| 12 | Colle Capital Partners | New York, United States | 3 | 16 | Findigs, RADAR, Qureos |
| 13 | Avenue Capital Group | New York, United States | 2 | 3 | Unrivaled, Cosm |
| 14 | Apollo | New York, United States | 2 | 7 | CAIS, Kashable |
| 15 | Invus | New York, United States | 2 | 25 | Lycia Therapeutics, Triveni Bio |
Table 3. Post IPO investors in New York City: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Latest rounds in their portfolios
Newest first| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors on this list | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Easol | Easol provides software for managing bookings, ticketing, payments, and customer relationships. | Commerce | London, United Kingdom | Series A | $20.0M | 2026-10-28 | $59.6M | Tiger Global Management | 11 to 50 | 2017 |
| Mach9 | Mach9 builds a geospatial production platform for engineering and construction firms, starting with Digital Surveyor. | Artificial intelligence | San Francisco, United States | Series A | $34.5M | 2026-10-21 | $51.3M | Tiger Global Management | 11 to 50 | 2021 |
| Rebill | Rebill provides financial infrastructure for businesses and platforms operating across the Americas. | Commerce | Miami, United States | Seed | $5.4M | 2026-10-20 | $9.0M | Tiger Global Management | 11 to 50 | 2020 |
| Tenstorrent Unicorn | Tenstorrent develops AI processors and software for machine learning and data-intensive workloads. | Artificial intelligence | Santa Clara, United States | Series E | $1.5B | 2026-10-19 | $2.5B | Moore Capital | 501 to 1,000 | 2016 |
| Meow | Meow offers businesses interest-bearing checking accounts, treasury services, invoicing, and bill pay. | Fintech | New York, United States | Series B | $31.6M | 2026-10-15 | $58.6M | Tiger Global Management | 11 to 50 | 2021 |
| ICON Unicorn | ICON builds construction technology, including 3D-printed homes and structures, for projects on Earth and beyond. | Artificial intelligence | Austin, United States | Series D | $200.0M | 2026-10-13 | $772.8M | Tiger Global Management | 251 to 500 | 2017 |
| Ramp Unicorn | Ramp provides software for corporate spend management, finance operations, and business payments. | Artificial intelligence | New York, United States | Series G | $1.9B | 2026-10-09 | $5.6B | Citi | 1,001 to 5,000 | 2019 |
| Capitolis Unicorn | Capitolis provides technology and financial solutions that improve capital efficiency and reduce capital markets risk. | Fintech | New York, United States | Series E | $120.0M | 2026-10-06 | $557.8M | Citi, JP Morgan | 51 to 100 | 2017 |
| Multiply Labs | Multiply Labs builds robotic systems that automate biologics manufacturing. | Artificial intelligence | San Francisco, United States | Series B | $75.0M | 2026-10-06 | $97.7M | Casdin Capital | 11 to 50 | 2016 |
| Rightway Unicorn | Rightway provides a health technology service that lowers healthcare costs and improves patient outcomes. | Health care | New York, United States | Series E | $155.0M | 2026-09-24 | $394.3M | Tiger Global Management | 501 to 1,000 | 2017 |
Table 4. Post IPO investors in New York City: the 10 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.
Portfolio sectors
| Portfolio sectors | Companies | Share |
|---|---|---|
| Software | 610 | 71% |
| Fintech | 210 | 24% |
| Artificial intelligence | 191 | 22% |
| Health care | 166 | 19% |
| Hardware | 116 | 13% |
| Biotech | 103 | 12% |
| Commerce | 99 | 11% |
| Cybersecurity | 63 | 7% |
| Education | 31 | 4% |
| Energy | 17 | 2% |
Table 5. Post IPO investors in New York City: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.
Investment stages
| Investment stages | Investors | Share |
|---|---|---|
| Post IPO investors | 188 | 100% |
| Early stage investors | 137 | 73% |
| Late stage investors | 123 | 65% |
| Private equity investors | 108 | 57% |
| Venture investors | 89 | 47% |
| Seed investors | 82 | 44% |
| Debt investors | 69 | 37% |
| Convertible note investors | 30 | 16% |
Table 6. Post IPO investors in New York City by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.
Founded
| Founded | Investors | Share |
|---|---|---|
| 2020s | 7 | 4% |
| 2010s | 60 | 36% |
| 2000s | 33 | 20% |
| 1990s | 29 | 18% |
| 1980s | 19 | 12% |
| 1970s | 4 | 2% |
Table 7. Post IPO investors in New York City by founding decade. Source: FundingWatcher. Data as of 16 November 2026.
Method
- An investor is on this list when its recorded investment stages include post ipo investors and its headquarters is in New York City. On 16 November 2026 that is 188 investors.
- 105 rows carry an email address and 131 a phone number from the investor file. Investments, lead investments and exits are the counts the source records.
- The table prints the first 30 rows by recorded investments that carry a website and a location, with email and phone masked. The CSV carries all 188 rows: 13 have no website and 0 no location.
Sources, fields and exclusions of both files: Method.
Questions
- How many post ipo investors in New York City are on the list?
- 188, in the file dated 16 November 2026. 24 of them invested in a company whose most recent round falls in the last 12 months.
- How many have an email address?
- 105 of the 188 carry an email address in the download and 131 a phone number.
- What does the CSV contain?
- One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
- How much does the list cost?
- $29 one-time for all 188 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV with 188 rows, 105 firm email addresses and 131 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 76 of the 105 are inboxes such as info@ or contact@. No partner names.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.